News
-
-
-
COMMUNIQUÉ DE PRESSE
Radius Pharmaceuticals Announces Licensing Agreement with Pharmanovia to Register and Commercialize Abaloparatide in China and Select Asia Pacific Territories
Radius Pharmaceuticals grants Pharmanovia exclusive commercialization rights to abaloparatide in Asia Pacific region for osteoporosis treatment, expanding global market presence -
-
-
COMMUNIQUÉ DE PRESSE
Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia
Radius Pharmaceuticals grants Theramex exclusive commercialization rights to ELADYNOS® for osteoporosis treatment in select regions, expanding global market access
